---
title: "Ocean Power Technologies files Form 3 for Chief Commercial Officer Jason Weed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300823727.md"
description: "Ocean Power Technologies filed Form 3 for Chief Commercial Officer Jason Weed, disclosing direct holdings of 20,196 common shares and 23,790 restricted stock units. The filing was published via EDGAR on October 2, 2026."
datetime: "2026-10-02T20:06:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300823727.md)
  - [en](https://longbridge.com/en/news/300823727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300823727.md)
generator: "portal-rs"
---

# Ocean Power Technologies files Form 3 for Chief Commercial Officer Jason Weed

-   Ocean Power Technologies Chief Commercial Officer Jason Eugene Weed filed an initial Form 3 showing 20,196 shares of common stock held directly. \* Disclosure also listed 23,790 restricted stock units. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocean Power Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-045513), on October 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [OPTT.US](https://longbridge.com/en/quote/OPTT.US.md)

## Related News & Research

- [Ocean Power Technologies highlights record $20.1 million contract backlog in investor presentation](https://longbridge.com/en/news/298351669.md)
- [Ocean Power Technologies Lowers Note Conversion and Warrant Exercise Prices to $2.45](https://longbridge.com/en/news/300164588.md)
- [Summit Therapeutics Publishes Presentation on Ivonescimab Phase 3 Biliary Tract Cancer Trial](https://longbridge.com/en/news/302998438.md)
- [Kaldvík Lenders Extend Waiver Period Through Oct. 26, 2026](https://longbridge.com/en/news/302998578.md)
- [I'd Buy Half a Position in Amazon Stock Before Its Oct. 29 Report -- and Half After](https://longbridge.com/en/news/303054275.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**